Normal Aging Induces A1-Like Astrocyte Reactivity PNAS PLUS

Total Page:16

File Type:pdf, Size:1020Kb

Normal Aging Induces A1-Like Astrocyte Reactivity PNAS PLUS Normal aging induces A1-like astrocyte reactivity PNAS PLUS Laura E. Clarkea,1, Shane A. Liddelowa,b,c, Chandrani Chakrabortya, Alexandra E. Müncha, Myriam Heimand,e,f, and Ben A. Barresa,2 aDepartment of Neurobiology, Stanford University, School of Medicine, Stanford, CA 94305; bNeuroscience Institute, NYU Langone Medical Center, New York, NY 10016; cDepartment of Neuroscience and Physiology, NYU Langone Medical Center, New York, NY 10016; dBroad Institute of MIT and Harvard, Cambridge, MA 02142; ePicower Institute for Learning and Memory, Cambridge, MA 02139; and fDepartment of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139 Edited by Carla J. Shatz, Stanford University, Stanford, CA, and approved January 19, 2018 (received for review December 12, 2017) The decline of cognitive function occurs with aging, but the activated morphology in aged brains (17). The extent to which mechanisms responsible are unknown. Astrocytes instruct the astrocytes also become activated with age is unknown, although formation, maturation, and elimination of synapses, and impair- it is reported that the level of glial fibrillary acidic protein ment of these functions has been implicated in many diseases. (GFAP) and vimentin, two astrocyte-specific genes linked to These findings raise the question of whether astrocyte dysfunc- activation, increase with age in both rodents and humans (18, tion could contribute to cognitive decline in aging. We used the 19). Regardless, the transcriptional and functional changes oc- Bac-Trap method to perform RNA sequencing of astrocytes from curring in astrocytes in normal aging are not well understood. different brain regions across the lifespan of the mouse. We found The up-regulation of potentially proinflammatory genes by that astrocytes have region-specific transcriptional identities that microglia in normal aging raises the question of whether these change with age in a region-dependent manner. We validated our aging-induced changes in microglia could promote the activation of findings using fluorescence in situ hybridization and quantitative astrocytes. Recently, we reported that proinflammatory microglia PCR. Detailed analysis of the differentially expressed genes in secrete IL-1α, TNF, and C1q, and that these cytokines acting to- aging revealed that aged astrocytes take on a reactive phenotype gether are necessary and sufficient to activate astrocytes (9). These of neuroinflammatory A1-like reactive astrocytes. Hippocampal cytokines induce the formation of a subtype of astrocytes (termed and striatal astrocytes up-regulated a greater number of reactive A1 astrocytes) which are strongly neurotoxic and rapidly kill neu- astrocyte genes compared with cortical astrocytes. Moreover, aged brains formed many more A1 reactive astrocytes in response rons (9). As well as releasing a potent neurotoxin, A1 astrocytes NEUROSCIENCE to the neuroinflammation inducer lipopolysaccharide. We found were less able to promote the formation of new synapses, and that the aging-induced up-regulation of reactive astrocyte genes caused a decrease in the excitatory function of CNS neurons. In was significantly reduced in mice lacking the microglial-secreted addition to changes in the reactive state of astrocytes, it is possible cytokines (IL-1α, TNF, and C1q) known to induce A1 reactive astro- that other transcriptional and functional changes are occurring in cyte formation, indicating that microglia promote astrocyte acti- astrocytes that contribute to cognitive decline in normal aging. vation in aging. Since A1 reactive astrocytes lose the ability to To investigate the transcriptional changes occurring in astro- carry out their normal functions, produce complement compo- cytes with aging, we performed RNA sequencing (RNAseq) at five nents, and release a toxic factor which kills neurons and oligoden- ages across the lifespan of the mouse to determine the aging-induced drocytes, the aging-induced up-regulation of reactive genes by astrocytes could contribute to the cognitive decline in vulnerable Significance brain regions in normal aging and contribute to the greater vul- nerability of the aged brain to injury. In aging, the brain becomes vulnerable to injury and cognitive function declines, but the mechanisms responsible are un- astrocytes | aging | microglia | RNA sequencing | cognitive decline known. Astrocytes, the most abundant class of glial cells, are vital for the proper function of the central nervous system, and strocytes are the most abundant glial cells and are vital for impairment of astrocyte function has been implicated in dis- Athe proper function of the central nervous system (CNS). ease. Here we perform RNA sequencing of astrocytes from They perform many roles, including instructing the formation (1– different brain regions across the lifespan of the mouse to 3) and elimination (4) of neuronal synapses during development. identify age-related transcriptional changes that could con- In addition, they provide trophic support to neurons (5), mediate tribute to cognitive decline. We find that aged astrocytes take uptake and recycling of neurotransmitters (6), and are involved on a reactive phenotype characteristic of neuroinflammatory in maintenance of the blood–brain barrier (7). Given the mul- reactive astrocytes, and that microglia play a role in inducing titude of vital roles for astrocytes, it is not surprising that im- astrocyte activation. The aging astrocyte RNA sequencing pairment of these functions has been implicated in the profiles provide an important new resource for future studies pathogenesis of many diseases. In particular, astrocyte dysfunc- exploring the role of astrocytes in cognitive decline. tion has been linked to age-related neurodegenerative diseases, including Alzheimer’sdisease(8–10), dementia (11), and amyo- Author contributions: L.E.C. and B.A.B. designed research; L.E.C., S.A.L., C.C., A.E.M., and M.H. performed research; M.H. contributed new reagents/analytic tools; L.E.C. and S.A.L. trophic lateral sclerosis (ALS) (12, 13). Several hallmarks of analyzed data; and L.E.C. and B.A.B. wrote the paper. these neurodegenerative diseases, such as cognitive decline Conflict of interest statement: B.A.B. was a cofounder of Annexon Biosciences Inc., a and a loss of working memory, also occur during the process company working to make new drugs for treatment of neurological diseases. of normal aging. This article is a PNAS Direct Submission. Transcriptomics and epigenetic studies have reported that This open access article is distributed under Creative Commons Attribution-NonCommercial- glial-specific gene expression patterns change significantly with NoDerivatives License 4.0 (CC BY-NC-ND). normal aging, while neuron-specific gene expression patterns Data deposition: The data reported in this paper have been deposited in the BioProject change relatively little in comparison (14). For instance, micro- database, https://www.ncbi.nlm.nih.gov/bioproject (accession no. PRJNA417856). glia, the resident immune cells of brain, up-regulate immune 1To whom correspondence should be addressed. Email: [email protected]. response signaling receptors (15), and neuroprotective signaling 2Deceased December 27, 2017. pathways (16) in aged mice. Consistent with the observed tran- This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. scriptional changes, there is evidence that microglia adopt an 1073/pnas.1800165115/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1800165115 PNAS Latest Articles | 1of10 Downloaded by guest on September 30, 2021 transcriptional changes occurring in astrocytes. Furthermore, we phenotype in different brain regions (hippocampus, striatum, profiled astrocytes from three functionally distinct brain and cortex) we generated an RNAseq profiling resource of regions—the hippocampus, striatum and cortex—at these five adolescent [postnatal day 7 (P7)], young adult (P32), mature ages, to investigate brain-region−specific changes in the astrocyte (10 wk), middle age (9.5 mo), and aged (2 y) astrocytes. A major transcriptome in normal aging. Our RNAseq data revealed that limitation to sequencing older CNS tissues is the successful pu- astrocytes have distinct region-dependent transcriptional identi- rification of intact, viable astrocytes with minimal isolation arti- ties and age in a regionally dependent manner. In particular, we fact. To overcome this difficulty, we used the Aldh1l1-eGFP- found that astrocytes in regions more vulnerable to cognitive L10a transgenic mouse line (Fig. 1A), which expresses a fusion of decline—the hippocampus and striatum—undergo more dra- eGFP and a ribosomal protein (L10a) under the control of the matic transcriptional changes compared with cortical astrocytes. astrocyte-specific Aldh1l1 gene. Translating ribosome affinity Differential gene expression analysis revealed that the most purification (TRAP) (21, 22) of this fusion protein yields the prominent class of genes up-regulated by aged astrocytes were ribosome and its associated mRNAs, allowing the isolation of reactive astrocyte genes. Interestingly, many of these reactive transcripts from the eGFP-expressing astrocytes. To first assess astrocyte genes are characteristic A1 reactive astrocyte genes that the specificity of ALDH1L1-eGFP-L10a protein expression in are induced in response to neuroinflammation (9, 20). We found adult mice (10 wk of age), we performed immunohistochemistry that the aging-induced up-regulation of
Recommended publications
  • Astrocyte Cell Culture Preparation of Flasks: 1
    Astrocyte Cell Culture Preparation of flasks: 1. Coat T75 flask(s) with 1 mg/ml of PureCol (Collagen) overnight 2. Remove solution, rinse flasks with sterile ddH20, set the flasks upright and allow to dry in culture hood for 2 hr Dissection: 1. Dissect P1-P3 pups: Remove brainstem, cerebellum and diencephalons in cold dissection buffer. Peel off meninges and transfer cortex to a 50 ml tube on ice, which contains 20 ml of cold dissection buffer. (Dissect 2 pups for 2 x 106 cells/flask). 2. Carefully pour tissue into a 10 cm dish and gently mince tissue with sterile scissors or razor blade. 3. Transfer tissue to back to 50 ml tube and add 5 ml 1X trypsin and 50 uL DNAse for 25 min at 37ºC. Swirl tube every 5 min. 4. Wash the cortices with Glial Medium twice. 5. Dissociate the tissue by gently triturating the cortices through a 5 ml or 2 ml pipette, followed by a fire-polished Pasteur pipette (3 X 3 triturations). Each time fill pipette with dissociated cells and transfer supernatant to a fresh tube. 6. Dilute cell suspension to 10 ml of Glial Medium, and pass through a 40 uM cell strainer. 7. Spin down the cells at 1700 rpm for 5 min. 8. Re-suspend the cells with 10 ml of Glial Medium, and count. 9. Seed 2 x 106 cells/flask in 15 ml Glial medium. ****(2.0 x 106 cells/flask = 1.33 x 105 cells/ml = 2.67 x 104 cells/cm2)***** 10. Change the medium each of the next two days by aspirating the medium, and then adding back 15 ml of fresh Glial Medium.
    [Show full text]
  • Regulation of Myelin Structure and Conduction Velocity by Perinodal Astrocytes
    Correction NEUROSCIENCE Correction for “Regulation of myelin structure and conduc- tion velocity by perinodal astrocytes,” by Dipankar J. Dutta, Dong Ho Woo, Philip R. Lee, Sinisa Pajevic, Olena Bukalo, William C. Huffman, Hiroaki Wake, Peter J. Basser, Shahriar SheikhBahaei, Vanja Lazarevic, Jeffrey C. Smith, and R. Douglas Fields, which was first published October 29, 2018; 10.1073/ pnas.1811013115 (Proc. Natl. Acad. Sci. U.S.A. 115,11832–11837). The authors note that the following statement should be added to the Acknowledgments: “We acknowledge Dr. Hae Ung Lee for preliminary experiments that informed the ultimate experimental approach.” Published under the PNAS license. Published online June 10, 2019. www.pnas.org/cgi/doi/10.1073/pnas.1908361116 12574 | PNAS | June 18, 2019 | vol. 116 | no. 25 www.pnas.org Downloaded by guest on October 2, 2021 Regulation of myelin structure and conduction velocity by perinodal astrocytes Dipankar J. Duttaa,b, Dong Ho Wooa, Philip R. Leea, Sinisa Pajevicc, Olena Bukaloa, William C. Huffmana, Hiroaki Wakea, Peter J. Basserd, Shahriar SheikhBahaeie, Vanja Lazarevicf, Jeffrey C. Smithe, and R. Douglas Fieldsa,1 aSection on Nervous System Development and Plasticity, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892; bThe Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817; cMathematical and Statistical Computing Laboratory, Office of Intramural Research, Center for Information
    [Show full text]
  • Microglia Activation Triggers Astrocyte-Mediated Modulation of Excitatory Neurotransmission
    Microglia activation triggers astrocyte-mediated PNAS PLUS modulation of excitatory neurotransmission Olivier Pascuala,b,c,1,2, Sarrah Ben Achoura,b,c,2, Philippe Rostainga,b,c, Antoine Trillera,b,c, and Alain Bessisa,b,c aInstitut de Biologie de l’Ecole Normale Supérieure, F-75005 Paris, France; bInstitut National de la Santé et de la Recherche Médicale U1024, F-75005 Paris, France; and cCentre National de la Recherche Scientifique, Unité Mixte de Recherche 8197, F-75005 Paris, France Edited* by Tullio Pozzan, University of Padova, Padua, Italy, and approved November 21, 2011 (received for review July 18, 2011) Fine control of neuronal activity is crucial to rapidly adjust to subtle tatively able to sense neuronal activity and/or communicate with changes of the environment. This fine tuning was thought to be astrocytes. In response to stimuli, microglia are activated, and they purely neuronal until the discovery that astrocytes are active players release neurotransmitters (19), which are small molecules such as of synaptic transmission. In the adult hippocampus, microglia are nitric oxide, trophic factors, or cytokines, all known to control the other major glial cell type. Microglia are highly dynamic and neuronal function and synaptic transmission (20, 21). In addition, closely associated with neurons and astrocytes. They react rapidly to changes in plasticity and neuronal activity have been shown to modifications of their environment and are able to release mole- modify the resident time of microglia processes at synapses (22). cules known to control neuronal function and synaptic transmission. Although long-term effects of microglial activation and in- Therefore, microglia display functional features of synaptic part- flammation have been studied (14, 23, 24), early consequences of ners, but their involvement in the regulation of synaptic trans- such activation are still unknown, especially the cell type involved mission has not yet been addressed.
    [Show full text]
  • Astrocyte Failure As a Cause of CNS Dysfunction
    Molecular Psychiatry (2000) 5, 230–232 2000 Macmillan Publishers Ltd All rights reserved 1359-4184/00 $15.00 www.nature.com/mp NEWS & VIEWS Astrocyte failure as a cause of CNS dysfunction All insults to the central nervous systems (CNS), expressing HSV-Tk from the mouse Gfap promoter, including injury, ischemia, infection and degenerative reactive, transgene-expressing astrocytes adjacent to a disease are invariably accompanied by the hypertro- forebrain stab injury are ablated by GCV.8,9 These and phy, altered gene expression and proliferation of astro- other studies have demonstrated the essential nature of cytes, a process commonly referred to as ‘reactive astrocyte functions in a number of contexts related to astrocytosis’. While much is known about molecules the response to injury, and highlighted how astrocyte that either influence, or are produced by, reactive astro- failure might lead to CNS dysfunction in various ways. cytes,1,2 the functions of these cells are incompletely understood. Astrocytes are the most numerous cells in Astrocytes, the blood–brain barrier and interstitial the vertebrate central nervous system (CNS), and vari- edema ous functions have been ascribed to them in the unin- jured CNS, including: provision of structural support The anatomical correlate of the BBB is thought to for neural elements (neuro-glia = neural ‘glue’); homeo- reside in tight junctions between endothelial cells of static maintenance of the extracellular ionic environ- cerebral capillaries, which are of high electrical resist- ment and pH;
    [Show full text]
  • Laboratory Activities Biomedik I
    Laboratory Activities Biomedik I Nerve Tissue First Year of Medical Faculty Unisba 1 2019 Laboratory Activities Histology: Nerve Tissue Writer : Wida Purbaningsih, dr., MKes Editor : Wida Purbaningsih, dr., MKes Date : October, 2019 A Sequence I. Introduction : 30 min II. Pre Test : 5 min III. Activity Lab : 120 min - Discussion : 30 min - Identify : 90 min B Topic 1. General microstructure of nerve tissue 2. General microstructure of the neuron and neuroglia 3. Microstructure of the Ganglion 4. Microstructure of the Meningens C Venue Biomedical Laboratory Faculty of Medicine, Bandung Islamic Universtity D Equipment 1. Light microscopy 2. Stained tissue section: 3. Colouring pencils Slide 1. Motor Neuron Neuron 2. Cerebrum neuroglia 3. Cerebellum Meningen 4. Medulla spinalis Ganglia: 5. Ganglion otonom Sensoric ganglia 6. Ganglion Sensorik Autonomic ganglia E Pre-requisite - Before following the laboratory activity, the students must prepare : 1. Mention the types of cells that exist in nerve tissue ! 2. Draw the schematic picture of neuron cell and give explanation 3. Mention six type of neuroglia and describe their functional (astrocyte, microglia, oligodendrosit, sel schwan, epenymal cell, and satellite cells), then draw the schematic neuroglia and give explanation 4. Draw the schematic picture of sensoric ganglion microsructure and give explanation 5. Draw the schematic picture of otonom ganglion microsructure and give explanation 2 6. Draw the schematic picture of meningens microstructure and give explanation about tissue type - Content lab in manual book ( pre and post test will be taken from the manual, if scorring pre test less than 50, can not allowed thelab activity) - Bring your text book, reference book e.q atlas of Histology, e-book etc.
    [Show full text]
  • Astroglial NF-Kb Contributes to White Matter Damage and Cognitive Impairment in a Mouse Model of Vascular Dementia
    Saggu et al. Acta Neuropathologica Communications (2016) 4:76 DOI 10.1186/s40478-016-0350-3 RESEARCH Open Access Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia Raman Saggu1, Toni Schumacher1, Florian Gerich1, Cordula Rakers1, Khalid Tai1, Andrea Delekate1 and Gabor C. Petzold1,2* Abstract Vascular cognitive impairment is the second most common form of dementia. The pathogenic pathways leading to vascular cognitive impairment remain unclear but clinical and experimental data have shown that chronic reactive astrogliosis occurs within white matter lesions, indicating that a sustained pro-inflammatory environment affecting the white matter may contribute towards disease progression. To model vascular cognitive impairment, we induced prolonged mild cerebral hypoperfusion in mice by bilateral common carotid artery stenosis. This chronic hypoperfusion resulted in reactive gliosis of astrocytes and microglia within white matter tracts, demyelination and axonal degeneration, consecutive spatial memory deficits, and loss of white matter integrity, as measured by ultra high-field magnetic resonance diffusion tensor imaging. White matter astrogliosis was accompanied by activation of the pro-inflammatory transcription factor nuclear factor (NF)-kB in reactive astrocytes. Using mice expressing a dominant negative inhibitor of NF-kB under the control of the astrocyte-specific glial fibrillary acid protein (GFAP) promoter (GFAP-IkBα-dn), we found that transgenic inhibition of astroglial NF-kB signaling ameliorated gliosis and axonal loss, maintained white matter structural integrity, and preserved memory function. Collectively, our results imply that pro-inflammatory changes in white matter astrocytes may represent an important detrimental component in the pathogenesis of vascular cognitive impairment, and that targeting these pathways may lead to novel therapeutic strategies.
    [Show full text]
  • The Role of Satellite Glial Cells, Astrocytes, and Microglia in Oxaliplatin-Induced Neuropathic Pain
    biomedicines Review The Role of Satellite Glial Cells, Astrocytes, and Microglia in Oxaliplatin-Induced Neuropathic Pain Ji Hwan Lee and Woojin Kim * Department of Physiology, College of Korean Medicine, Kyung Hee University, Seoul 02453, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-2-961-0334 Received: 15 August 2020; Accepted: 31 August 2020; Published: 2 September 2020 Abstract: Oxaliplatin is a third-generation platinum-based chemotherapeutic drug. Although its efficacy against colorectal cancer is well known, peripheral neuropathy that develops during and after infusion of the agents could decrease the quality of life of the patients. Various pathways have been reported to be the cause of the oxaliplatin-induced paresthesia and dysesthesia; however, its mechanism of action has not been fully understood yet. In recent years, researchers have investigated the function of glia in pain, and demonstrated that glia in the peripheral and central nervous system could play a critical role in the development and maintenance of neuropathic pain. These results suggest that targeting the glia may be an effective therapeutic option. In the past ten years, 20 more papers focused on the role of glia in oxaliplatin-induced thermal and mechanical hypersensitivity. However, to date no review has been written to summarize and discuss their results. Thus, in this study, by reviewing 23 studies that conducted in vivo experiments in rodents, the change of satellite glial cells, astrocytes, and microglia activation in the dorsal root ganglia, spinal cord, and the brain of oxaliplatin-induced neuropathic pain animals is discussed. Keywords: astrocytes; chemotherapy-induced neuropathic pain; glia; microglia; oxaliplatin 1.
    [Show full text]
  • No Preliminary Evidence of Differences in Astrocyte Density Within the White Matter of the Dorsolateral Prefrontal Cortex In
    Lee et al. Molecular Autism (2017) 8:64 DOI 10.1186/s13229-017-0181-5 SHORT REPORT Open Access No preliminary evidence of differences in astrocyte density within the white matter of the dorsolateral prefrontal cortex in autism Ting Ting Lee1,2* , Efstratios Skafidas1,2,7, Mirella Dottori2,3,9, Daniela Zantomio4, Christos Pantelis1,2,6,7, Ian Everall1,2,7,8† and Gursharan Chana1,2,5,7† Abstract Background: While evidence for white matter and astrocytic abnormalities exist in autism, a detailed investigation of astrocytes has not been conducted. Such an investigation is further warranted by an increasing role for neuroinflammation in autism pathogenesis, with astrocytes being key players in this process. We present the first study of astrocyte density and morphology within the white matter of the dorsolateral prefrontal cortex (DLPFC) in individuals with autism. Methods: DLPFC formalin-fixed sections containing white matter from individuals with autism (n =8,age=4–51 years) and age-matched controls (n =7,age=4–46 years) were immunostained for glial fibrillary acidic protein (GFAP). Density of astrocytes and other glia were estimated via the optical fractionator, astrocyte somal size estimated via the nucleator, and astrocyte process length via the spaceballs probe. Results: We found no evidence for alteration in astrocyte density within DLPFC white matter of individuals with autism versus controls, together with no differences in astrocyte somal size and process length. Conclusion: Our results suggest that astrocyte abnormalities within the white matter in the DLPFC in autism may be less pronounced than previously thought. However, astrocytic dysregulation may still exist in autism, even in the absence of gross morphological changes.
    [Show full text]
  • Astrocyte-Like Glia in the Peripheral Nervous System: an Immunohistochemical Study of Enteric Glia’
    0270-6474/83/0311-2206$02.00/O The Journal of Neuroscience Copyright 0 Society for Neuroscience Vol. 3, No. 11, pp. 2206-2218 Printed in U.S.A. November 1983 ASTROCYTE-LIKE GLIA IN THE PERIPHERAL NERVOUS SYSTEM: AN IMMUNOHISTOCHEMICAL STUDY OF ENTERIC GLIA’ KRISTJAN R. JESSEN*,2 AND RHONA MIRSKY$ *MRC Neuroimmunology Group, Department of Zoology, and $ Department of Anatomy and Embryology, University College, Gower Street, London WClE 6BT, England Received January $1983; Revised May 4,1983; Accepted May 5, 1983 Abstract The similarities between the enteric nervous system of the gut and the central nervous system (CNS), both of which function as complex integrative nervous networks, include striking ultrastruc- tural similarities between the glia of the enteric nervous sytem and the astrocytic glia of the CNS. In this paper we have determined whether this anatomical resemblance also extends to the molecular level by examining the enteric glial cells to see whether they express several surface and intracellular molecules which are highly restricted to glia and to astrocytes in particular. Indirect immunofluores- ence was used to visualize the antigens in frozen sections of gut wall and in whole mount, tissue culture, and freshly dissected preparations of myenteric and submucous plexuses from rats of various ages. It was found that enteric glial cells expressed the intracellular proteins glial fibrillary acidic protein, glutamine synthetase, and vimentin both in situ and in culture. The surface antigen Ran- 2 was expressed in situ but not in culture, and the surface antigen Ran-l was expressed in culture but not in situ. Cultured enteric glial cells did not express fibronectin in significant quantity, nor did they make galactocerebroside.
    [Show full text]
  • Bone Morphogenetic Proteins Induce Astroglial Differentiation of Oligodendroglial–Astroglial Progenitor Cells
    The Journal of Neuroscience, June 1, 1997, 17(11):4112–4120 Bone Morphogenetic Proteins Induce Astroglial Differentiation of Oligodendroglial–Astroglial Progenitor Cells P. C. Mabie, M. F. Mehler, R. Marmur, A. Papavasiliou, Q. Song, and J. A. Kessler Departments of Neurology and Neuroscience and the R. F. Kennedy Center for Research in Mental Retardation and Human Development, Albert Einstein College of Medicine, Bronx, New York 10461 We have used bipotent postnatal cortical oligodendroglial- survival and accelerated exit from cell cycle. Dual-label immuno- astroglial progenitor cells (O-2As) to examine the role of inductive fluorescence microscopy documents that O-2A progenitor cells signals in astroglial lineage commitment. O-2A progenitor cells express a complement of BMP type I and type II receptor subunits undergo progressive oligodendroglial differentiation when cultured required for signal transduction. Furthermore, expression of BMP2 in serum-free medium, but differentiate into astrocytes in medium in vivo reaches maximal levels during the period of gliogenesis. supplemented with FBS. We now report that the bone morpho- These results suggest that the BMPs act as potent inductive genetic proteins (BMPs), a major subclass of the transforming factors in postnatal glial lineage commitment that initiate a stable growth factor b (TGFb) superfamily, promote the selective, dose- program of astroglial differentiation. dependent differentiation of O-2As into astrocytes with concurrent suppression of oligodendroglial differentiation. This astroglial- Key words: astrocyte; bone morphogenetic protein; lineage inductive action is not sanctioned by other members of the TGFb commitment; oligodendrocyte-astrocyte type 2 progenitor; superfamily. Astroglial differentiation requires only very brief initial transforming growth factor b superfamily; central nervous sys- exposure to the BMPs and is accompanied by increased cellular tem development Normal mammalian CNS development requires the progressive man, 1993).
    [Show full text]
  • Astrocyte Morphogenesis Is Dependent on BDNF Signaling Via
    RESEARCH ARTICLE Astrocyte morphogenesis is dependent on BDNF signaling via astrocytic TrkB.T1 Leanne M Holt1,2, Raymundo D Hernandez2,3, Natasha L Pacheco1, Beatriz Torres Ceja2, Muhannah Hossain2, Michelle L Olsen1,2* 1Department of Cell, Developmental, and Integrative Biology, School of Medicine, University of Alabama at Birmingham, Birmingham, United States; 2School of Neuroscience, Virginia Polytechnic and State University, Blacksburg, United States; 3Graduate Program in Translational Biology, Medicine, and Health, Virginia Polytechnic Institute and State University, Blacksburg, United States Abstract Brain-derived neurotrophic factor (BDNF) is a critical growth factor involved in the maturation of the CNS, including neuronal morphology and synapse refinement. Herein, we demonstrate astrocytes express high levels of BDNF’s receptor, TrkB (in the top 20 of protein- coding transcripts), with nearly exclusive expression of the truncated isoform, TrkB.T1, which peaks in expression during astrocyte morphological maturation. Using a novel culture paradigm, we show that astrocyte morphological complexity is increased in the presence of BDNF and is dependent upon BDNF/TrkB.T1 signaling. Deletion of TrkB.T1, globally and astrocyte-specifically, in mice revealed morphologically immature astrocytes with significantly reduced volume, as well as dysregulated expression of perisynaptic genes associated with mature astrocyte function. Indicating a role for functional astrocyte maturation via BDNF/TrkB.T1 signaling, TrkB.T1 KO astrocytes do not support normal excitatory synaptogenesis or function. These data suggest a significant role for BDNF/TrkB.T1 signaling in astrocyte morphological maturation, a critical process for CNS development. *For correspondence: Introduction [email protected] Astrocyte maturation is a crucial developmental process for normal CNS function.
    [Show full text]
  • Mapping Astrocyte Transcriptional Signatures in Response to Neuroactive Compounds
    International Journal of Molecular Sciences Article Mapping Astrocyte Transcriptional Signatures in Response to Neuroactive Compounds Debosmita Sardar 1, Brittney Lozzi 2, Junsung Woo 1, Teng-Wei Huang 1, Caroline Cvetkovic 3, Chad J. Creighton 4,5, Robert Krencik 3 and Benjamin Deneen 1,6,7,* 1 Center for Cell and Gene Therapy, Stem Cells and Regenerative Medicine Center, Baylor College of Medicine, Houston, TX 77030, USA; [email protected] (D.S.); [email protected] (J.W.); [email protected] (T.-W.H.) 2 Genetics and Genomics Graduate Program, Baylor College of Medicine, Houston, TX 77030, USA; [email protected] 3 Department of Neurosurgery, Center for Neuroregeneration, Houston Methodist Research Institute, Houston, TX 77030, USA; [email protected] (C.C.); [email protected] (R.K.) 4 Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA; [email protected] 5 Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA 6 Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA 7 Department of Neurosurgery, Baylor College of Medicine, Houston, TX 77030, USA * Correspondence: [email protected] Abstract: Astrocytes play central roles in normal brain function and are critical components of synaptic networks that oversee behavioral outputs. Despite their close affiliation with neurons, how neuronal-derived signals influence astrocyte function at the gene expression level remains poorly characterized, largely due to difficulties associated with dissecting neuron- versus astrocyte- Citation: Sardar, D.; Lozzi, B.; Woo, specific effects. Here, we use an in vitro system of stem cell-derived astrocytes to identify gene J.; Huang, T.-W.; Cvetkovic, C.; expression profiles in astrocytes that are influenced by neurons and regulate astrocyte development.
    [Show full text]